We are live on ! Find out more
IG

Ithaka Group Portfolio holdings

AUM $482M
1-Year Est. Return 15.81%
This Fund
S&P 500
This Quarter Est. Return
+11.44%
1 Year Est. Return
+15.81%
3 Year Est. Return
+99.18%
5 Year Est. Return
+112.16%
10 Year Est. Return
+745.06%
AUM
$632M
AUM Growth
-$6.08M
Cap. Flow
-$55.4M
Cap. Flow %
-8.77%
Top 10 Hldgs %
47.21%
Holding
46
New
3
Increased
8
Reduced
26
Closed
4

Top Buys

Rank Stock Value
1
TJX icon
TJX Companies
TJX
+$13.6M
2
PANW icon
Palo Alto Networks
PANW
+$5.7M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$5.34M
4
BIIB icon
Biogen
BIIB
+$4.61M
5
MIDD icon
Middleby
MIDD
+$3.69M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$27.2M
2
CMI icon
Cummins
CMI
+$15.3M
3
LVS icon
Las Vegas Sands
LVS
+$13.9M
4
META icon
Meta Platforms (Facebook)
META
+$3.98M
5
SBUX icon
Starbucks
SBUX
+$2.68M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 24.25%
2 Communication Services 22.8%
3 Healthcare 15.25%
4 Technology 12.87%
5 Financials 8.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MON
26
DELISTED
Monsanto Co
MON
$11.5M 1.83%
102,461
-9,956
-9% -$1.18M
WDAY icon
27
Workday
WDAY
$33.4B
$11.2M 1.78%
132,920
-9,726
-7% -$822K
BIDU icon
28
Baidu
BIDU
$35.8B
$10.7M 1.7%
51,471
-5,118
-9% -$1.1M
ALXN
29
DELISTED
Alexion Pharmaceuticals
ALXN
$10.7M 1.69%
61,479
-5,751
-9% -$1.04M
JCI icon
30
Johnson Controls International
JCI
$87.5B
$10.6M 1.68%
200,550
TRIP icon
31
TripAdvisor
TRIP
$1.59B
$10M 1.59%
120,379
-7,183
-6% -$565K
BEAV
32
DELISTED
B/E Aerospace Inc
BEAV
$8.89M 1.41%
139,744
-12,654
-8% -$777K
BMRN icon
33
BioMarin Pharmaceuticals
BMRN
$11.5B
$6.28M 0.99%
+50,361
New +$5.34M
PANW icon
34
Palo Alto Networks
PANW
$264B
$6.2M 0.98%
+254,772
New +$5.7M
MNDT
35
DELISTED
Mandiant, Inc. Common Stock
MNDT
$4.02M 0.64%
102,431
-5,628
-5% -$217K
KLXI
36
DELISTED
KLX Inc.
KLXI
$2.71M 0.43%
83,483
-6,819
-8% -$228K
AMT icon
37
American Tower
AMT
$77.7B
$356K 0.06%
3,777
+677
+22% +$65.8K
MSFT icon
38
Microsoft
MSFT
$2.84T
$264K 0.04%
6,500
TROW icon
39
T. Rowe Price
TROW
$25B
$259K 0.04%
3,200
LVS icon
40
Las Vegas Sands
LVS
$30.5B
$247K 0.04%
4,495
-248,982
-98% -$13.9M
PG icon
41
Procter & Gamble
PG
$343B
$246K 0.04%
3,000
GE icon
42
GE Aerospace
GE
$367B
$223K 0.04%
1,878
CMI icon
43
Cummins
CMI
$91.7B
-106,006
Closed -$15.3M
GILD icon
44
Gilead Sciences
GILD
$161B
-289,042
Closed -$27.2M
IWF icon
45
iShares Russell 1000 Growth ETF
IWF
$122B
-63,672
Closed -$1.52M
NKE icon
46
Nike
NKE
$61.9B
-5,062
Closed -$243K

Similar funds

Ithaka Group's Q1 2015 Portfolio in Review

As of Q1 2015, Ithaka Group held 46 positions worth $632M, down 0.95% from $638M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Ithaka Group withdrew a net $55.4M in Q1 2015, closing 4 positions and reducing 26 holdings. Its most notable exit was Gilead Sciences, an estimated $27.2M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 24% of assets, down from 25% a quarter earlier, followed by Communication Services and Healthcare.

Against the trend, Ithaka Group opened a new position in TJX Companies worth $13.9M.

  • Ithaka Group's largest Q1 2015 buy was TJX Companies: 398,194 shares worth $13.9M.
  • Ithaka Group added most to Biogen in Q1 2015, an estimated $4.61M increase.
  • Ithaka Group's biggest Q1 2015 reduction was Las Vegas Sands, cutting an estimated $13.9M.
  • Ithaka Group fully exited Gilead Sciences in Q1 2015, selling an estimated $27.2M.
  • Ithaka Group's ten largest holdings make up 47% of its $632M portfolio in Q1 2015.
  • Ithaka Group opened 3 new positions and closed 4 in Q1 2015.
  • Ithaka Group's portfolio value fell 0.95% quarter-over-quarter to $632M.

Based on Ithaka Group's 13F filing for Q1 2015, filed 11 May 2015.